Medication info

Pabiz Ranitidine Tablet

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›168mg / 1 tablet
Manufacturer / importer
Korea Pavis Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 199102269 · Notified 1991.12.03

This product's status changed to Expired on 2025.04.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of gastric acid disorders (e.g., ulcers), improvement of gastric mucosal lesions, prevention of Mendelson's syndrome
Who takes it
Adults · Children
Adult dose
Adults: Administer 150 mg of ranitidine orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 150 mg of this medication orally twice daily, or 300 mg once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 300 mg twice daily, in the morning and at bedtime. The dosage and administration are the same when this medication is used concomitantly to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term administration of nonsteroidal anti-inflammatory drugs. These conditions usually heal within 4 weeks; conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medication, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 150 mg of this medication twice daily for 8 weeks, or 300 mg once daily at bedtime. The dose may be increased to 150 mg 4 times daily for patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Begin treatment with an initial dose of 150 mg of this medication 3 times daily; the dose may be increased as needed. For severe cases, up to 6 g per day may be administered as directed by a physician. 4) For upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions, treatment is usually initiated with an injectable formulation. Once oral administration is possible, switch to oral administration and give 150 mg of this medication twice daily. 5) Preanesthetic medication (prevention of Mendelson syndrome) Administer 150 mg of this medication 2 hours before induction of anesthesia. In this case, it is also preferable to administer 150 mg on the night before surgery. 6) Improvement of gastric mucosal lesions (erosions, bleeding, redness, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Administer 150 mg of this medication once daily at bedtime. 3. Patients with renal impairment For patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. The dosing interval may be extended to 12 hours or longer depending on the patient's condition. Hemodialysis reduces the blood concentration of the medication; therefore, adjust the dosing schedule immediately after hemodialysis. Adjust the dose appropriately according to age and symptoms.
Child dose
For patients 12 years of age and older, administer 75 mg of this medication orally twice daily (liquid formulation only). For ages 8 〜 18 years, up to 150 mg per dose (2 mg per kg of body weight) may be administered twice daily.

Ingredients

Manufacturer
Korea Pavis Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastric acid disorders (e.g., ulcers), improvement of gastric mucosal lesions, prevention of Mendelson's syndrome

  • Gastric and duodenal ulcers
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • postoperative ulcers
  • gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drug (NSAID) administration
  • gastric mucosal lesions
  • erosion
  • bleeding
  • redness
  • swelling
  • acute gastritis
View approved original text

This medication is used for the treatment of ulcers in the stomach and duodenum, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It also aids in the prevention of Mendelson's syndrome prior to surgery and in the treatment of postoperative ulcers. It is effective for ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). It is used to improve gastric mucosal lesions, such as erosion, bleeding, redness, and swelling during acute exacerbations of acute and chronic gastritis. It is also applied in the treatment of peptic ulcers accompanied by upper gastrointestinal bleeding, acute stress ulcers, and acute gastric mucosal lesions. It helps alleviate symptoms of heartburn or acid regurgitation, thereby improving excessive gastric acid issues.

How to take

Adult dose

Adults: Administer 150 mg of ranitidine orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 150 mg of this medication orally twice daily, or 300 mg once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 300 mg twice daily, in the morning and at bedtime. The dosage and administration are the same when this medication is used concomitantly to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term administration of nonsteroidal anti-inflammatory drugs. These conditions usually heal within 4 weeks; conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medication, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 150 mg of this medication twice daily for 8 weeks, or 300 mg once daily at bedtime. The dose may be increased to 150 mg 4 times daily for patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Begin treatment with an initial dose of 150 mg of this medication 3 times daily; the dose may be increased as needed. For severe cases, up to 6 g per day may be administered as directed by a physician. 4) For upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions, treatment is usually initiated with an injectable formulation. Once oral administration is possible, switch to oral administration and give 150 mg of this medication twice daily. 5) Preanesthetic medication (prevention of Mendelson syndrome) Administer 150 mg of this medication 2 hours before induction of anesthesia. In this case, it is also preferable to administer 150 mg on the night before surgery. 6) Improvement of gastric mucosal lesions (erosions, bleeding, redness, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Administer 150 mg of this medication once daily at bedtime. 3. Patients with renal impairment For patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. The dosing interval may be extended to 12 hours or longer depending on the patient's condition. Hemodialysis reduces the blood concentration of the medication; therefore, adjust the dosing schedule immediately after hemodialysis. Adjust the dose appropriately according to age and symptoms.

Child dose

For patients 12 years of age and older, administer 75 mg of this medication orally twice daily (liquid formulation only). For ages 8 〜 18 years, up to 150 mg per dose (2 mg per kg of body weight) may be administered twice daily.

Precautions

This medication should not be used in certain patients. Patients allergic to this drug or its components should not take it. Patients with a history of acute porphyria, which is a rare disorder, should also not use this drug. Additionally, this medication contains lactose; therefore, patients with lactose intolerance or certain genetic metabolic disorders should not take it. For patients with poor kidney function, this medication may remain in the body longer and increase concentration, so dosage should be reduced or the dosing interval should be extended for careful use. Patients with weak liver function, a history of drug allergies, and elderly patients should also use this medication with caution. Patients taking non-steroidal anti-inflammatory drugs should have their condition regularly monitored, especially elderly patients or those with a history of peptic ulcers. This medication may mask symptoms of gastric cancer; thus, patients over middle age with gastric ulcers or new or changing dyspeptic symptoms should confirm malignancy before taking it. Patients with Helicobacter pylori infections in their stomach or duodenal ulcers need to undergo eradication treatment. Though rare, this medication can cause serious allergic reactions, such as anaphylactic shock, necessitating immediate discontinuation and appropriate treatment if adverse symptoms occur during administration. Allergic symptoms such as urticaria, rash, shortness of breath, and hypotension may also appear, so caution is necessary. Blood test abnormalities may occur, and if symptoms like fatigue, bleeding, or fever arise, the hospital should be notified immediately. Temporary liver function impairment may manifest, so if jaundice or hepatitis symptoms appear, medication should be discontinued. Gastrointestinal symptoms like arrhythmia, constipation, nausea, abdominal pain have been reported, while neurological symptoms such as dizziness, drowsiness, headaches, confusion, and insomnia may also occur. Especially, patients with reduced kidney function or the elderly should be more vigilant to these symptoms. This medication has been rarely associated with various adverse effects such as gynecomastia, erectile dysfunction, myalgia, and skin rashes, so any unusual symptoms should be discussed with healthcare providers. During treatment, regular tests for blood, liver, and kidney function should occur; if symptoms do not improve, alternate treatment methods should be considered. Elderly patients or those with chronic illnesses may have an increased risk of pneumonia and should be cautious; if dizziness or drowsiness occurs, driving or handling hazardous machinery should be avoided. This medication may interact with other drugs, so if there are any other medications being taken, it is essential to inform healthcare professionals. Co-administration with anticoagulants such as warfarin requires careful monitoring of blood clotting status. Women who are pregnant or may become pregnant need to consider the benefits and risks of administering this medication cautiously. Nursing mothers should only take it when necessary, as it may be passed through breast milk. Safety in children has not been thoroughly established, so caution is advised for their use. Keep this medication out of reach of children, and transferring it to another container may compromise its quality. In case of overdose, specific symptoms of poisoning are rare, but emergency measures such as vomiting or gastric lavage may be necessary. This medication reduces gastric acid secretion, which can promote bacterial growth in the stomach; therefore, regular check-ups, including eye exams, are recommended with long-term use.

Side effects

  • Anaphylactic shock
  • urticaria
  • angioedema
  • rash
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • elevated serum creatinine level
Show 59 more
  • leukocytopenia
  • thrombocytopenia
  • aplastic anemia
  • bone marrow aplasia
  • hypoplastic anemia
  • agranulocytosis
  • pancytopenia
  • acquired immune hemolytic anemia
  • eosinophilia
  • generalized fatigue
  • weakness
  • subcutaneous bleeding
  • mucosal bleeding
  • fever
  • liver dysfunction
  • jaundice
  • hepatitis
  • bradycardia
  • atrioventricular block
  • tachycardia
  • vasculitis
  • constipation
  • nausea
  • vomiting
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • diarrhea
  • acute pancreatitis
  • dizziness
  • drowsiness
  • convulsions
  • headache
  • feelings of heaviness in the head
  • insomnia
  • agitation
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorder
  • consciousness disorder
  • liver hypertonic muscle cramps
  • gynecomastia
  • excessive milk secretion
  • erectile dysfunction
  • decreased libido
  • joint pain
  • muscle pain
  • rhabdomyolysis
  • skin rash
  • erythema multiforme
  • alopecia
  • glossitis
  • skin itching
  • ocular mucosal syndrome
  • toxic epidermal necrolysis
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in containers that do not allow light to enter. Additionally, it is best to store it at room temperature between 1 to 30 degrees Celsius. Proper storage maintains the medication's efficacy and safety.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.